Morgan Stanley Galapagos Nv Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Galapagos Nv stock. As of the latest transaction made, Morgan Stanley holds 84,355 shares of GLPG stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,355

Previous 113,729 25.83%

Holding current value

$2.27 Million

Previous $2.82 Million 13.84%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$24.2 - $30.67 $710,850 - $900,900	-29,374 Reduced 25.83%	84,355 $2.43 Million
Q2 2024 Oct 17, 2024	BUY	$24.78 - $32.48 $2.23 Million - $2.93 Million	90,067 Added 380.64%	113,729 $2.82 Million
Q2 2024 Aug 14, 2024	BUY	$24.78 - $32.48 $2.23 Million - $2.93 Million	90,067 Added 380.64%	113,729 $2.82 Million
Q1 2024 Oct 17, 2024	SELL	$32.2 - $42.44 $2.9 Million - $3.82 Million	-90,067 Reduced 79.19%	23,662 $761,000
Q1 2024 Aug 16, 2024	SELL	$32.2 - $42.44 $2.82 Million - $3.72 Million	-87,668 Reduced 78.75%	23,662 $761,000
Q1 2024 May 15, 2024	SELL	$32.2 - $42.44 $2.82 Million - $3.72 Million	-87,668 Reduced 78.75%	23,662 $761,000
Q4 2023 Aug 16, 2024	SELL	$31.87 - $40.71 $76,456 - $97,663	-2,399 Reduced 2.11%	111,330 $4.53 Million
Q4 2023 Feb 13, 2024	BUY	$31.87 - $40.71 $2.8 Million - $3.58 Million	87,980 Added 376.79%	111,330 $4.53 Million
Q3 2023 Nov 15, 2023	SELL	$34.17 - $42.98 $383,182 - $481,977	-11,214 Reduced 32.44%	23,350 $806,000
Q2 2023 Aug 14, 2023	SELL	$37.4 - $44.52 $2.71 Million - $3.22 Million	-72,427 Reduced 67.69%	34,564 $1.41 Million
Q1 2023 May 15, 2023	SELL	$36.5 - $48.0 $499,028 - $656,256	-13,672 Reduced 11.33%	106,991 $4.13 Million
Q4 2022 Feb 14, 2023	SELL	$37.44 - $46.51 $2.21 Million - $2.75 Million	-59,024 Reduced 32.85%	120,663 $5.36 Million
Q3 2022 Nov 14, 2022	SELL	$42.27 - $57.6 $379,965 - $517,766	-8,989 Reduced 4.76%	179,687 $7.66 Million
Q2 2022 Oct 27, 2022	BUY	$52.3 - $71.59 $1.97 Million - $2.7 Million	37,662 Added 24.94%	188,676 $10.5 Million
Q2 2022 Aug 15, 2022	BUY	$52.3 - $71.59 $1.97 Million - $2.7 Million	37,662 Added 24.94%	188,676 $10.5 Million
Q1 2022 Oct 27, 2022	SELL	$51.32 - $68.5 $1.93 Million - $2.58 Million	-37,662 Reduced 19.96%	151,014 $9.37 Million
Q1 2022 May 13, 2022	BUY	$51.32 - $68.5 $2.55 Million - $3.4 Million	49,639 Added 48.97%	151,014 $9.37 Million
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $1.93 Million - $2.34 Million	-40,951 Reduced 28.77%	101,375 $5.59 Million
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $7.43 Million - $9.99 Million	142,326 New	142,326 $7.49 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.77B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account